ILUMYA® (tildrakizumab-asmn) | reSURFACE 1 & 2 Study Results
SponsoredHCPs: Examine the Clinical Trial Safety Profile for ILUMYA® for reSURFACE 1 & 2. Analy…Stay Connected · Clinical Studies · Safety Profile · Prescribing Information
Moderate To Severe PsO | Plaque Psoriasis
SponsoredHCPs, View Safety & Efficacy Data For A Moderate To Severe PsO Treatment Option. Le…Long-Term Study Data · Official HCP Site · PsO Symptom Relief · Administration Resources
Types: HCP Resources, Prescribing Info, Safety Profile, Clinical Trial Results

Feedback